Preventive check-ups through blood tests in certified laboratories, translated into a health dashboard.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series A Lucis (Paris) raised $20M in a Series A led by Singular, with General Catalyst and Y Combinator, bringing the total to $28M for its biomarker-based preventive health platform. | $20M |
| Dec 2025 | Seed Paris-based Lucis, backed by YC, raised an $8.5 million seed led by General Catalyst to democratize preventive blood testing in Europe. | $8.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.